ASLAN Pharmaceuticals’ Varlitinib Selected by Leading Korean Gastric Cancer Group for Study in Second-Line Gastric Cancer

    NEXT STORY
    Global Companion Diagnostics Market to Witness a CAGR of 19% During 2019-2025
    PREV STORY
    Esoteric Testing Market revenue to hit $39 Billion by 2025: Global Market Insights, Inc.
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Geron Reports Imetelstat Oral Presentation at European Hematology Association Congress

    Updated Clinical Data from Original Part 1 of IMerge in Myelodysplastic Syndromes (MDS) PresentedMENLO ...

    author_avatar
    NASDAQ Market News

    XBiotech Announces Publication of Breakthrough Findings for Potential Role of Interleukin-1 alpha in Risk for Heart Attacks

    Findings Demonstrate Ability of MABp1 (Bermekimab) to Block In Vitro Neutrophil Mediated Vascular Endothelial ...

    author_avatar
    NASDAQ Market News

    UroGen Pharma to Host Third Quarter 2017 Financial Results Conference Call on Tuesday, November 14, 2017

    RA’ANANA, Israel and NEW YORK, Nov. 08, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. ...

    author_avatar
    NASDAQ Market News